Acute pancreatitis secondary to the use of the anabolic steroid trenbolone acetate

Acute pancreatitis secondary to the use of the anabolic steroid trenbolone acetate / Vidhya Kumar, Danny Issa, George Smallfield, Doumit Bouhaidar. - (Clinical Toxicology 57 (2019) 1 (12 August); p. 60-62)

  • PMID: 30101635
  • DOI: 10.1080/15563650.2018.1491983


Background: The use of performance-enhancing drugs has increased dramatically in the last decade with high prevalence reported among the young athlete population. Many of these drugs contain anabolic steroids and may carry potential significant side effects and health risks. We report a case of anabolic steroid-induced acute pancreatitis (AP) that recurred after the reuse of the same drug by the patient, confirming the causative relationship.

Case report: A 24 year-old male presented with severe epigastric pain. His past medical history was significant for two hospitalizations during the last year with AP. During his hospital admissions, extensive workup was performed ruling out the common and uncommon causes of AP. Upon further pressing, the patient admitted to a history of past and current anabolic steroid use for athletic performance enhancement. He began this use four years ago and most recently started using trenbolone acetate (TA). The correlation between the timing of the anabolic steroids administration and the attacks of AP, along with ruling out other causes, confirmed TA as the cause of pancreatitis.

Discussion: The side effects associated with the use of these increasingly prevalent drugs are difficult to study in clinical trials due to the unethical nature of their consumption. In addition, these medications are difficult to study due to the varied usage cycles and patterns, unknown origin and source, as well as often high dose ingestion. Physicians and body builders need to be aware of the possible serious consequences of their use.


Case report
12 August 2019
Bouhaidar, Doumit
Issa, Danny
Kumar, Vidhya
Smallfield, George
United States of America
Other organisations
Virginia Commonwealth University School of Medicine
Doping classes
S1. Anabolic Agents
Trenbolone (17β-hydroxyestr-4,9,11-trien-3-one)
Medical terms
Health effects
Document category
Date generated
2 December 2020
Date of last modification
5 December 2020
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period